おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
Novelion Therapeutics
About
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company
- 251 - 500
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $50M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 1981
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 25, 2021 | Post-IPO Debt | $50M | 1 |
Hercules Capital
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
